Search Results

Amcinonide 100 mg  | Purity Not Available

TargetMol

Amcinonide is a Corticosteroid. The mechanism of action of amcinonide is as a Corticosteroid Hormone Receptor Agonist.

More Information Supplier Page

Amcinonide 50 mg  | Purity Not Available

TargetMol

Amcinonide is a Corticosteroid. The mechanism of action of amcinonide is as a Corticosteroid Hormone Receptor Agonist.

More Information Supplier Page

Lesinurad 200 mg  | Purity Not Available

TargetMol

Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout. Lesinurad has had a limited clinical use but has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.

More Information Supplier Page

Lesinurad 50 mg  | Purity Not Available

TargetMol

Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout. Lesinurad has had a limited clinical use but has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.

More Information Supplier Page

Lesinurad 25 mg  | Purity Not Available

TargetMol

Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout. Lesinurad has had a limited clinical use but has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.

More Information Supplier Page

Lesinurad 10 mg  | Purity Not Available

TargetMol

Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout. Lesinurad has had a limited clinical use but has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.

More Information Supplier Page

Capivasertib 50 mg  | 99.29%

TargetMol

Capivasertib (AZD5363) is a new-type orally available inhibitor of the serine/threonine protein kinase AKT (IC50s: 3/7/7 nM for Akt1/2/3).

More Information Supplier Page

Capivasertib 10 mg  | 99.29%

TargetMol

Capivasertib (AZD5363) is a new-type orally available inhibitor of the serine/threonine protein kinase AKT (IC50s: 3/7/7 nM for Akt1/2/3).

More Information Supplier Page

Capivasertib 2 mg  | 99.29%

TargetMol

Capivasertib (AZD5363) is a new-type orally available inhibitor of the serine/threonine protein kinase AKT (IC50s: 3/7/7 nM for Akt1/2/3).

More Information Supplier Page